"Receptors, Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors.
| Descriptor ID |
D017483
|
| MeSH Number(s) |
D12.776.543.750.695.910 D12.776.543.750.720.600.925 D12.776.543.750.750.555.925 D12.776.543.750.750.660.900
|
| Concept/Terms |
Receptors, Vasopressin- Receptors, Vasopressin
- Antidiuretic Hormone Receptors
- Hormone Receptors, Antidiuretic
- Receptors, Antidiuretic Hormone
- Vasopressin Receptor
- Receptor, Vasopressin
- Vasopressin Receptors
Vasopressin V1a Receptor- Vasopressin V1a Receptor
- Vasopressin Type 1A Receptor
- Antidiuretic Hormone Receptor 1a
- Vascular-Hepatic Type Arginine Vasopressin Receptor
- Vascular Hepatic Type Arginine Vasopressin Receptor
- V1a Vasopressin Receptor
Vasopressin V2 Receptor- Vasopressin V2 Receptor
- Receptors, V2
- Antidiuretic Hormone Receptor
- Hormone Receptor, Antidiuretic
- Receptor, Antidiuretic Hormone
- Renal-Type Arginine Vasopressin Receptor
- Renal Type Arginine Vasopressin Receptor
- V2 Receptor
- Receptor, V2
- V2 Receptors
Vasopressin Receptor 1- Vasopressin Receptor 1
- Receptors, V1
- V1 Receptors
- 8-Arg-Vasopressin Receptor
- 8 Arg Vasopressin Receptor
- Argipressin Receptors
- Receptors, Argipressin
- Receptor, Arginine(8)-Vasopressin
- Argipressin Receptor
- Receptor, Argipressin
- V1 Receptor
- Receptor, V1
- Arginine Vasopressin Receptor
- Receptor, Arginine Vasopressin
Vasopressin V1b Receptor- Vasopressin V1b Receptor
- Receptor, Vasopressin V1b
- V1b Receptor, Vasopressin
- Antidiuretic Hormone Receptor 1b
- Vasopressin V3 Receptor
- Receptor, Vasopressin V3
- V1b Vasopressin Receptor
- Vasopressin Receptor, V1b
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Vasopressin".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Vasopressin [D12.776.543.750.695.910]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Vasopressin [D12.776.543.750.720.600.925]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Vasopressin [D12.776.543.750.750.555.925]
- Receptors, Pituitary Hormone [D12.776.543.750.750.660]
- Receptors, Vasopressin [D12.776.543.750.750.660.900]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Vasopressin".
This graph shows the total number of publications written about "Receptors, Vasopressin" by people in this website by year, and whether "Receptors, Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2008 | 3 | 1 | 4 |
| 2011 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Vasopressin" by people in Profiles.
-
Goparaju P, Gragnoli C. Implication of vasopressin receptor genes (AVPR1A and AVPR1B) in the susceptibility to polycystic ovary syndrome. J Ovarian Res. 2024 Nov 05; 17(1):214.
-
Li X, Chan TO, Myers V, Chowdhury I, Zhang XQ, Song J, Zhang J, Andrel J, Funakoshi H, Robbins J, Koch WJ, Hyslop T, Cheung JY, Feldman AM. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gaq-mediated cell signaling. Circulation. 2011 Aug 2; 124(5):572-81.
-
Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. 2008 Dec; 217(3):605-17.
-
Whellan DJ. Introduction: Vasopressin therapy. Heart Fail Rev. 2009 Jun; 14(2):57-8.
-
Kumar SK, Mather PJ. AVP receptor antagonists in patients with CHF. Heart Fail Rev. 2009 Jun; 14(2):83-6.
-
Fuentes LQ, Reyes CE, Sarmiento JM, Villanueva CI, Figueroa CD, Navarro J, Gonz?lez CB. Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways. Cell Signal. 2008 Sep; 20(9):1642-50.
-
Sarmiento JM, Ehrenfeld P, A?azco CC, Reyes CE, Troncoso S, Figueroa CD, M?ller-Esterl W, Gonz?lez CB. Differential distribution of the vasopressin V receptor along the rat nephron during renal ontogeny and maturation. Kidney Int. 2005 Aug; 68(2):487-96.